Skin Cancer

>

Latest News

Green and pink model of a melanoma cell
NCCN Guidelines Update Includes HEPZATO KIT for Uveal Melanoma

February 25th 2025

Updates to the NCCN guidelines recommend HEPZATO KIT for use in hepatic-dominant uveal melanoma as a Category 2A treatment option.

Illustration of a clipboard with the word "Guidelines" on top of the page, followed by a check list
NCCN Guideline Updates on ctDNA Stance in MCC and Colon, Rectal Cancer

February 22nd 2025

dark blue background with a white outline indicating layers of skin
Cemiplimab as Adjuvant Therapy Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma

January 20th 2025

Image of FDA on a clipboard.
Cosibelimab Approved by FDA for Metastatic, Locally Advanced Cutaneous Squamous Cell Carcinoma

December 13th 2024

FDA on clipboard
Accelerated Approval Sought for RP1-Nivolumab Combo for Pretreated Melanoma

November 24th 2024

Latest CME Events & Activities

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

View More

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

View More

More News